Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2023-08-04 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board meeting scheduled for 14.08.2023. The agenda includes consideration of un-audited financial results for the quarter ended 30.06.2023 and other business. The document is brief (1358 characters) and serves as an announcement of a future event rather than containing actual financial data or detailed reports. It does not contain the financial results themselves, nor detailed management discussion or other report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and notices that do not fit other categories.
2023-08-04 English
Updates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate submitted under Regulation 3(5) of SEBI (Prohibition of Insider Trading) Regulations, 2015, for the quarter ended June 30, 2023. It certifies the maintenance and control of a Structured Digital Database (SDD) related to insider trading compliance. The document is addressed to stock exchanges and signed by the Managing Director and Compliance Officer. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance certificate rather than a financial report or announcement. The document length is short (2911 characters) and it is a certification letter. According to the rules, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS).
2023-07-21 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document text is extremely short (171 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings without substantive content.
2023-07-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 regarding the cancellation of the company's manufacturing license by the Drugs Control Administration, Government of Telangana. It is addressed to stock exchanges and provides details about the event, its impact, and corrective actions. The document is a regulatory announcement about a material event affecting the company, not a financial report or detailed management discussion. It fits the category of Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not contain financial statements or detailed report content.
2023-07-11 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (273 characters) and contains only a digital signature block with no substantive content, financial data, or report information. There is no indication of any report, announcement, or detailed filing. This matches the criteria for a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-06-30 English
Resignation
Regulatory Filings Classification · 100% confidence The document text is extremely short (229 characters) and consists solely of digital signature information without any substantive content, financial data, or report details. There is no indication of a report, announcement, or any specific filing type. Given the lack of content and the nature of the text, it does not fit into any specific report category and defaults to the fallback category for miscellaneous filings.
2023-06-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.